Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
1,366
Views
1
CrossRef citations to date
0
Altmetric
Biosimilars
Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan
Hala H. Halawaha Al-Zaytoonah University of Jordan, Amman, Jordan
https://orcid.org/0000-0002-3058-564X
Nimer S. Alkhatiba Al-Zaytoonah University of Jordan, Amman, Jordan;b Center for Health Outcomes and PharmacoEconomic Research, University of Arizon, Tucson, AZ, USA;c PI Pharma Intelligence, Amman, JordanCorrespondence[email protected]
https://orcid.org/0000-0001-5071-9257
Abdulaali R. Almutairid Saudi Food and Drug Authority, Riyadh, Saudi Arabia
https://orcid.org/0000-0002-3141-0606
Mohammad Saleha Al-Zaytoonah University of Jordan, Amman, Jordan;e School of Pharmacy, University of Jordan, Amman, Jordan
https://orcid.org/0000-0003-3298-094X
Shiraz S. Halloushf Applied Science Private University, Amman, Jordan
https://orcid.org/0000-0003-3966-2733
Omar Rashdang School of Pharmacy, Middle East University, Amman, Jordan
https://orcid.org/0000-0002-5192-4823
Lama Masadhh Ministry of Health, Amman, Jordan
, Osama H. Abusaraa Al-Zaytoonah University of Jordan, Amman, Jordan
https://orcid.org/0000-0002-0856-5618
Ivo Abrahamb Center for Health Outcomes and PharmacoEconomic Research, University of Arizon, Tucson, AZ, USA;i University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA;j Matrix45, Tucson, AZ, USA
https://orcid.org/0000-0003-0490-4421
Pages 835-842
|
Received 24 Mar 2023, Accepted 13 Jun 2023, Published online: 30 Jun 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.